Correction to: “Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells”, (Int. J. Cancer, (2010), 126, (337–349), 10.1002/ijc.24733);Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells

International Journal of Cancer

Volumn 126, Issue 2, 2010, Pages 337-349

  Mandal, Chandan ^a   Tringali, Cristina ^b   Mondal, Susmita ^a   Anastasia, Luigi ^b   Chandra, Sarmila ^c   Venerando, Bruno ^b   Mandal, Chitra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b UNIVERSITY OF MILAN   (Italy)

^c Kothari Medical Centre & Research Institute   (India)

Author keywords

9 O acetylated GD3; Acute lymphoblastic leukemia (ALL); Apoptosis; Gangliosides; Sialidase Neu3

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; CERAMIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GM3; LACTOSYLCERAMIDE; LIPOCORTIN 5; MEMBRANE PROTEIN; PROCASPASE 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN NEU1; PROTEIN NEU2; PROTEIN NEU3; PROTEIN NEU4; SIALIDASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFANT; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHOBLAST; MALE; NEU3 GENE; ONCOGENE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION;

EID: 73549095984     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.34888     Document Type: Erratum

References (50)

1. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371: 1030-43.
2. Varki A. Multiple changes in sialic acid biology during human evolution. Glycoconj J 2009;26:31-45.
3. Schauer R. Achievements and challenges of sialic acid research. Glycoconj J 2000;17: 485-99.
4. Vandamme-Feldhaus V, Schauer R. Characterization of the enzymatic 7-O-acetylation of sialic acids and evidence for enzymatic O-acetyl migration from C-7 to C-9 in bovine submandibular gland. J Biochem (Tokyo) 1998;124:111-21.
5. Corfield AP, Donapaty SR, Carrington SD, Hicks SJ, Schauer R, Kohla G. Identification of 9-O-acetyl-NCancer acetylneuraminic acid in normal canine pre-ocular tear film secreted mucins and its depletionin Keratoconjunctivitis sicca. Glycoconj J 2005;22:409-16.
6. Chava AK, Bandyopadhyay S, Chatterjee M, Mandal C. Sialoglycans in protozoal diseases; their detection, modes of acquisition and emerging biological roles. Glycoconj J 2004;20:199-206.
7. Ghoshal A, Mukhopadhyay S, Demine R, Forgber M, Jarmalavicius S, Saha B, Sundar S, Walden P, Mandal C, Mandal C. Detection and characterization of a sialoglycosylated bacterial ABC-type phosphate transporter protein from patients with visceral leishmaniasis. Glycoconj J. 2009;26:675-89.
8. Ansar W, Mukhopadhyay S, Basu S, Habib SKH, Saha B, Sen AK, Mandal C, Mandal C. Disease-associated glycosylated moleclar variants of human C-reactive protein activate complement-mediated hemolysis of erythrocytes in tuberculosis and Indian visceral leishmaniasis. Glycoconj J, 2009 Jun 5. DOI: 10.1007/s10719-009-9236-y [Epub ahead of print].
9. Corfield AP, MyerscoughN, Warren BF, Durdey P, Paraskeva C, Schauer R. Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence. Glycoconj J 1999;16: 307-17.
10. Ravindranaths MH, Paulson JC, Irie RF. Human melanoma antigen O-acetylated ganglioside GD3 is recognized by cancer antennarius lectin. J Biol Chem 1988;263: 2079-86.
11. Chowdhury S, Mandal C. O-acetylated sialic acids: multifaceted role in childhood acute lymphoblastic leukaemia. J Biotechnol 2009;4: 361-74.
12. Mandal C, Chatterjee M, Sinha D. Investigation of 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukemia. Br J Haematol 2000;110:801-12.
13. Erdmann M, Wipfler D, Merling A, Cao Y, Claus C, Kniep B, Sadick H, Bergler W, Vlasak R, Schwartz-Albiez R. Differential surface expression and possible function of 9-O- and 7-O-acetylated GD3 (CD60 b and c) during activation and apoptosis of human tonsillar B and T lymphocytes. Glycoconj J 2006;23:627-38.
14. Chen HY, Varki A. O-acetylation of GD3: an enigmatic modification regulating apoptosis? J Exp Med 2002;196:1529-33.
15. Ghosh S, Bandyopadhyay S, Mukherjee K, Mallick A, Pal S, Mandal C, Bhattacharya DK, Mandal C. O-acetylation of sialic acids is required for the survival of lymphoblasts in childhood acute lymphoblastic leukemia (ALL). Glycoconj J 2007;24:17-24.
16. Ghosh S, Bandyopadhyay S, Mullick A, Pal S, Vlasak R, Bhattacharya DK, Mandal C. Interferon gamma promotes survival of lymphoblasts over-expressing 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukemia (ALL). J Cell Biochem 2005;95:206-16.
17. Mukherjee K, Chava AK, Bandyopadhyay S, Mallick A, Chandra S, Mandal C. Co-expression of 9-O-acetylated sialoglycoproteins and their binding proteins on lymphoblasts of childhood acute lymphoblastic leukaemia: an antiapoptotic role. Biol Chem 2009;390: 325-35.
18. Mukherjee K, Chowdhury S, Mondal S, Mandal C, Chandra S, Bhadra RK, Mandal C. 9-O-acetylated GD3 triggers programmed cell death in mature erythrocytes. Biochem Biophys Res Commun 2007;362: 651-7.
19. Mukherjee K, Chava AK, Mandal C, Dey SN, Kniep B, Chandra S, Mandal C. O-Acetylation of GD3 prevents its apoptotic effect and promotes survival of lymphoblasts in childhood acute lymphoblastic leukaemia. J Cell Biochem 2008;105:724-34.
20. Bandyopadhyay S, Bhattacharyya A, Mallick A, Sen AK, Tripathi G, Das T, Sa G, Bhattacharya DK, Mandal C. Over-expressed IgG2 antibodies against O-acetylated sialoglycoconjugates incapable of proper effector functioning in childhood acute lymphoblastic leukemia. Int Immunol 2005;17:177-91.
21. H, as a probe. Leukemia 1999;13: 119-25.
22. Pal S, Ghosh S, Bandyopadhyay S, Mandal CN, Bandhyopadhyay S, Bhattacharya DK, Mandal C. Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: a potential tool for long-term monitoring of children with acute lymphoblastic leukaemia. Int J Cancer 2004;111:270-7.
23. Pal S, Ghosh S, Mandal CN, Kohla G, Brossmer R, Isecke R, Merling A, Schauer R, Schwartz-Albiez R, Bhattacharya DK, Mandal C. Purification and characterization of 9-O-acetylated sialoglycoproteins from leukaemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukaemia. Glycobiology 2004;14:859-70.
24. Ghosh S, Bhattacharya DK, Mandal C. Altered erythrocyte membrane characteristics during anemia in childhood acute lymphoblastic leukemia. Ann Hematol 2005;84:76-84.
25. Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 2005;5:526-42.
26. Chowdhury S, Bandyopadhyay S, Mandal C, Chandra S, Mandal C. Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up study. BMC Cancer 2008;8:40.
27. Sinha D, Mandal C, Bhattacharya DK. A novel method for prognostic evaluation of childhood acute lymphoblastic leukemia. Leukemia 1999;13:309-12.
28. Sinha D, Mandal C, Bhattacharya DK. A colorimetric assay to evaluate the chemotherapeutic response of children with acute lymphoblastic leukemia (ALL) employing achatinin: a 9-O-acetylated sialic acid binding lectin. Leukemia Res 1999;23: 803-9.
29. Pal S, Bandhyopadhyay S, Chatterjee M, Hall AG, Bhattacharya DK, Mandal C. Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukemia. Clin Biochem 2004;37:395-403.
30. Pal S, Chatterjee M, Bhattacharya DK, Bandhyopadhyay S, Mandal C, Mandal C. O-acetyl sialic acid specific IgM as a diagnostic marker in childhood acute lymphoblastic leukaemia. Glycoconj J 2001; 18:529-37.
31. Mandal C, Srinivasan GV, Chowdhury S, Chandra S, Mandal C, Schauer R, Mandal C. High level of sialate-O-acetyltransferase activity in lymphoblasts of childhood acute lymphoblastic leukaemia (ALL): enzyme characterization and correlation with disease status. Glycoconj J 2009;26: 57-73.
32. Monti E, Preti A, Venerando B, Borsani G. Recent development in mammalian sialidase molecular biology. Neurochem Res 2002;27: 649-63.
33. Miyagi T, Wada T, Yamaguchi K, Hata K. Sialidase and malignancy: a minireview. Glycoconj J 2004;20:189-98.
34. Papini N, Anastasia L, Tringali C, Croci G, Bresciani R, Yamaguchi K, Miyagi T, Preti A, Prinetti A, Prioni S, Sonnino S, Tettamanti G, et al. The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions. J Biol Chem 2004;279: 16989-95.
35. Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S, Miyagi T. A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells. Oncogene 2007;26: 2483-90.
36. Tringali C, Lupo B, Cirillo F, Papini N, Anastasia L, Lamorte G, Colombi P, Bresciani R, Monti E, Tettamanti G, Venerando B. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3. Cell Death Differ 2009;16:164-74.
37. Sonnino S, Nicolini M, Chigorno V. Preparation of radiolabeled gangliosides. Glycobiology 1996;6:757-63.
38. Sen G, Mandal C. A unique specificity of the binding site of achatinin-H, a sialic acid binding lectin from Achatina fulica. Carbohydr Res 1995;268:115-25.
39. Mandal C, Dutta A, Mallick A, Chandra S, Misra L, Sangwan R, Mandal C. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin in a transcriptiondependent manner through mitochondrial death cascade. Apoptosis 2008;13:1450-64.
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
41. Butor C, Diaz S, Varki A. High level Oacetylation of sialic acids on N-linked oligosaccharides of rat liver membranes. Differential subcellular distribution of 7- and 9-O-acetyl groups and of enzymes involved in their regulation. J Biol Chem 1993;268:10197-206.
42. Shukla AK, Schauer R. Fluorimetric determination of unsubstituted and 9(8)-O-acetylated sialic acids in erythrocyte membranes. Hoppe Seyler's. Z Physiol Chem 1982;363:255-62.
43. Dube DH, Bertozzi CR. Glycans in cancer and inflammation - potential for therapeutics and diagnostics. Nat Rev Drug Discov 2005;4: 477-88.
44. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996;56:5309-18.
45. Birkle S, Zeng G, Gao L, Yu RK, Aubry J. Role of tumor-associated gangliosides in cancer progression. Biochimie 2003;85: 455-63.
46. Wang Y, Yamaguchi K, Wada T, Hata K, Zhao X, Fujimoto T, Miyagi T. A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains. J Biol Chem 2002;277: 26252-9.
47. Kalka D, Von Reitzenstein C, Kopitz J, Cantz M. The plasma membrane ganglioside sialidase cofractionates with markers of lipid rafts. Biochem Biophys Res Commun 2001;283: 989-93.
48. Miyagi T, Wada T, Yamaguchi K. Roles of plasma membrane-associated sialidase NEU3 in human cancers. Biochim Biophys Acta 2008;1780: 532-7.
49. Valaperta R, Chigorno V, Basso L, Prinetti A, Bresciani R, Preti A, Miyagi T, Sonnino S. Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts. FASEB J 2006;20: 1227-9.
50. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993;259: 1769-71.